They accomplish this through the increased expression of IL‐6 and CXCL8, which support M2 macrophage polarization, and TGF‐β, which facilitates the recruitment and retention of macrophages in the TME and enables effective tumor evasion of the host immune system. The gene discussed is TGFB1; the disease is neoplasm.